Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype (original) (raw)

• Corey, S.J. et al. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat. Rev. Cancer 7, 118–129 (2007).
  Article CAS Google Scholar
• Nilsson, L. et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q–deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 96, 2012–2021 (2000).
  CAS PubMed Google Scholar
• Nilsson, L. et al. The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes. Blood 110, 3005–3014 (2007).
  Article CAS Google Scholar
• Thanopoulou, E. et al. Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. Blood 103, 4285–4293 (2004).
  Article CAS Google Scholar
• Nimer, S.D. Myelodysplastic syndromes. Blood 111, 4841–4851 (2008).
  Article CAS Google Scholar
• Li, X., Bryant, C.E. & Deeg, H.J. Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome. Int. J. Hematol. 80, 140–145 (2004).
  Article Google Scholar
• Giagounidis, A.A., Germing, U. & Aul, C. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies. Clin. Cancer Res. 12, 5–10 (2006).
  Article CAS Google Scholar
• Boultwood, J. et al. Narrowing and genomic annotation of the commonly deleted region of the 5q– syndrome. Blood 99, 4638–4641 (2002).
  Article CAS Google Scholar
• Martíinez-Ramirez, A. et al. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosom. Cancer 42, 287–298 (2005).
  Article Google Scholar
• Wang, L. et al. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. Haematologica 93, 994–1000 (2008).
  Article Google Scholar
• Ebert, B.L. et al. Identification of RPS14 as a 5q– syndrome gene by RNA interference screen. Nature 451, 335–339 (2008).
  Article CAS Google Scholar
• Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116, 281–297 (2004).
  Article CAS Google Scholar
• Ebert, M.S., Neilson, J.R. & Sharp, P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721–726 (2007).
  Article CAS Google Scholar
• Gentner, B. et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 6, 63–66 (2009).
  Article CAS Google Scholar
• Bigoni, R. et al. Multilineage involvement in the 5q– syndrome: a fluorescent in situ hybridization study on bone marrow smears. Haematologica 86, 375–381 (2001).
  CAS PubMed Google Scholar
• Kroef, M.J. et al. Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells. Leukemia 11, 519–523 (1997).
  Article CAS Google Scholar
• Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. & Burge, C.B. Prediction of mammalian microRNA targets. Cell 115, 787–798 (2003).
  Article CAS Google Scholar
• Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. NF-κB–dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481–12486 (2006).
  Article CAS Google Scholar
• Lamothe, B. et al. Site-specific Lys-63-linked tumor necrosis factor receptor–associated factor 6 auto-ubiquitination is a critical determinant of I κ B kinase activation. J. Biol. Chem. 282, 4102–4112 (2007).
  Article CAS Google Scholar
• Mansell, A., Brint, E., Gould, J.A., O'Neill, L.A. & Hertzog, P.J. Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-κB activation by Toll-like receptor (TLR)-2 and TLR4. J. Biol. Chem. 279, 37227–37230 (2004).
  Article CAS Google Scholar
• Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001).
  Article CAS Google Scholar
• Nimer, S.D. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q. J. Clin. Oncol. 24, 2576–2582 (2006).
  Article CAS Google Scholar
• Kishimoto, T. Interleukin-6: from basic science to medicine—40 years in immunology. Annu. Rev. Immunol. 23, 1–21 (2005).
  Article CAS Google Scholar
• Garzon, R. et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111, 3183–3189 (2008).
  Article CAS Google Scholar
• Marcucci, G. et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358, 1919–1928 (2008).
  Article CAS Google Scholar
• Takada, S. et al. MicroRNA expression profiles of human leukemias. Leukemia 22, 1274–1278 (2008).
  Article CAS Google Scholar
• Rakoff-Nahoum, S. & Medzhitov, R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124–127 (2007).
  Article CAS Google Scholar
• Bhaumik, D. et al. Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27, 5643–5647 (2008).
  Article CAS Google Scholar
• Chen, H. et al. Interference with nuclear factor κ B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis. Oncogene 25, 6520–6527 (2006).
  Article CAS Google Scholar
• Maratheftis, C.I., Andreakos, E., Moutsopoulos, H.M. & Voulgarelis, M. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin. Cancer Res. 13, 1154–1160 (2007).
  Article CAS Google Scholar
• Hofmann, W.K. et al. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 100, 3553–3560 (2002).
  Article CAS Google Scholar
• Gondek, L.P. et al. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD and MDS-derived AML. Blood 111, 1534–1542 (2008).
  Article CAS Google Scholar
• Starczynowski, D.T. et al. High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood 112, 3412–3424 (2008).
  Article CAS Google Scholar
• Garzon, R. et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc. Natl. Acad. Sci. USA 105, 3945–3950 (2008).
  Article CAS Google Scholar
• Garzon, R. et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111, 3183–3189 (2008).
  Article CAS Google Scholar
• Jongen-Lavrencic, M., Sun, S.M., Dijkstra, M.K., Valk, P.J. & Lowenberg, B. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111, 5078–5085 (2008).
  Article CAS Google Scholar
• Li, Z. et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. USA 105, 15535–15540 (2008).
  Article CAS Google Scholar
• Takada, S. et al. MicroRNA expression profiles of human leukemias. Leukemia 22, 1274–1278 (2008).
  Article CAS Google Scholar
• Hast, R., Eriksson, M., Widell, S., Arvidsson, I. & Bemell, P. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. Leuk. Res. 23, 579–584 (1999).
  Article CAS Google Scholar
• Herold, M., Schmalzl, F. & Zwierzina, H. Increased serum interleukin 6 levels in patients with myelodysplastic syndromes. Leuk. Res. 16, 585–588 (1992).
  Article CAS Google Scholar
• Verhoef, G.E. et al. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 6, 1268–1272 (1992).
  CAS PubMed Google Scholar
• Hsu, H.C. et al. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome. Oncology 63, 64–69 (2002).
  Article CAS Google Scholar
• Brandt, S.J., Bodine, D.M., Dunbar, C.E. & Nienhuis, A.W. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J. Clin. Invest. 86, 592–599 (1990).
  Article CAS Google Scholar
• Hawley, R.G., Fong, A.Z., Burns, B.F. & Hawley, T.S. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J. Exp. Med. 176, 1149–1163 (1992).
  Article CAS Google Scholar
• Corral, L.G. et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-α. J. Immunol. 163, 380–386 (1999).
  CAS PubMed Google Scholar
• Nagai, Y. et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801–812 (2006).
  Article CAS Google Scholar
• Tang, M. et al. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J. Exp. Med. 205, 1611–1619 (2008).
  Article CAS Google Scholar
• Antonchuk, J., Sauvageau, G. & Humphries, R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Exp. Hematol. 29, 1125–1134 (2001).
  Article CAS Google Scholar
• Larrivée, B., Pollet, I. & Karsan, A. Activation of vascular endothelial growth factor receptor-2 in bone marrow leads to accumulation of myeloid cells: role of granulocyte-macrophage colony-stimulating factor. J. Immunol. 175, 3015–3024 (2005).
  Article Google Scholar